Search Results

News Feed Opinion Career Insight Dialogues Blog Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
Sarah Cannon Research Institute
Jun 7, 2024, 13:10 | Opinion
Paolo Tarantino: Among the ASCO24 abstracts, particularly notable was the DB03 update
Erika Hamilton shared Paolo Tarantino's post on X, adding:           , "Agree, I…
Jun 7, 2024, 09:11 | Insight
Erika Hamilton: Happy to share the publication in Annals of Oncology
Erika Hamilton shared a post on X: “Happy to share the publication in Annals of…
Jun 7, 2024, 00:29 | Societies
Erika Hamilton: I am leaving ASCO24 filled with renewed energy and inspiration
Erika Hamilton shared a post on LinkedIn: "ASCO24 did not disappoint! So appreciative of Lynn…
Jun 6, 2024, 14:33 | Blog
Erika Hamilton: Thanks for fantastic ASCO24 leadership
Erika Hamilton shared on X/Twitter: "Thanks to Lynn Schuchter, Angie DeMichele, and Thomas LeBlanc for fantastic…
Jun 6, 2024, 00:46 | Opinion
Vivek Subbiah: Ishwaria Subbiah on a 5-year multicencer analysis of clinical trial
Vivek Subbiah shared a post on X: "Live now Ishwaria Subbiah is sharing the latest data…
Jun 5, 2024, 14:46 | Blog
Vivek Subbiah: Honored to meet with the visionary Dr. Rick Pazdur
Vivek Subbiah shared a post on X: "Honored to meet with the visionary Dr. Rick Pazdur…
Jun 5, 2024, 04:25 | Blog
Giuseppe Curigliano: Excited to see NBC News highlight the groundbreaking results of DESTINY-06
Giuseppe Curigliano reposted Erika Hamilton's post on LinkedIn, adding:    . "Excited to see NBC…
Jun 4, 2024, 16:28 | Societies
Erika Hamilton: Data that pCR translates to outcome in TNBC
Erika Hamilton shared a post on X: “PEARLY: Adriamycin Cyclophosphamide (AC) to Taxane versus AC…
Jun 4, 2024, 03:22 | Blog
Vivek Subbiah: Our amazing CSO Dr. Spigel will be presenting at the big plenary!
Vivek Subbiah shared on X/Twitter: "ASCO24 Sunday morning! Starting the day with Skip Burris, Conquer Cancer,…
Jun 3, 2024, 22:51 | Insight
Vivek Subbiah: The evolving landscape of tissue-agnostic therapies in precision oncology
Vivek Subbiah recently shared the following insight on LinkedIn: "HOT OFF THE PRESS Just in…
All: 444 Posts: 191 - 200
Special Coverage